Sponsor or institution
Clinical trials and research at Merlin Therapeutics INC
As of November 12, 2026, Find a Trial lists 2 NIH-funded research projects at this institution, with $2.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2NIH research projects
NIH-funded research (2)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
AAV-delivered ASC gene therapy targets schwannoma tumors
A tiny virus (AAV) would deliver a gene called ASC directly into schwannoma tumors to trigger tumor cell death and help people with NF2-related schwannomatosis or schwannomatosis.
-
New gene therapy for treating Neurofibromatosis Type 2
This study is testing a new gene therapy that aims to help people with Neurofibromatosis Type 2 (NF2) by delivering a healthy version of a gene that can prevent tumor growth, with the hope of easing symptoms and improving treatment options for those who currently have no approved therapies.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.